Comparison of surgical and oncological outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in upper and middle/lower rectal peritoneal metastases.

Date publication

août 2026

Journal

Surgical oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr MARCHAL Frédéric

Tous les auteurs :
Tidadini F, Ezanno AC, Sourrouille I, Glehen O, Dumont F, Quesada JL, Marchal F, Amroun KL, Pocard M, Kepenekian V, Fernandez de Sevilla E, Eveno C, Fischer J, Sage PY, Trilling B, Arvieux C, Faucheron JL,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/42648158

Résumé

We aim to assess the surgical and oncological outcomes of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in upper rectal peritoneal metastases (U_PM) versus middle/lower rectal peritoneal metastases (ML_PM).

Mots clés

Cytoreductive surgery (CRS), Hyperthermic intraperitoneal chemotherapy (HIPEC), Rectal peritoneal metastases (R_PM), Surgical and oncological outcomes

Référence

Surg Oncol. 2026 08 21;68:102539